Stereokem Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.23 Cr
as on 24-10-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 24-10-2024
- Satisfied Charges ₹ 1.40 Cr
as on 24-10-2024
- Revenue -20.87%
(FY 2023)
- Profit -18.80%
(FY 2023)
- Ebitda -12.31%
(FY 2023)
- Net Worth 18.31%
(FY 2023)
- Total Assets 34.15%
(FY 2023)
About Stereokem
The Corporate was formerly known as Dis Symmetrix Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.23 Cr.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹1.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Venkateshwar Kumar, Thaduri Srivani, and Venugopala Rao serve as directors at the Company.
- CIN/LLPIN
U24232TG2009PTC064427
- Company No.
064427
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Stereokem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkateshwar Kumar  | Director | 18-Jul-2009 | Current |
| Thaduri Srivani | Director | 16-Feb-2013 | Current |
| Venugopala Rao | Director | 30-Sep-2015 | Current |
Financial Performance of Stereokem.
Stereokem Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.87% decrease. The company also saw a substantial fall in profitability, with a 18.8% decrease in profit. The company's net worth Soared by an impressive increase of 18.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stereokem?
In 2023, Stereokem had a promoter holding of 98.37% and a public holding of 1.63%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Stereokem Pharmaceuticals Private LimitedActive 12 years 10 monthsVenkateshwar Kumar and Thaduri Srivani are mutual person
Jyostna Laboratories Private LimitedActive 16 years 2 monthsVenkateshwar Kumar and Thaduri Srivani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 Feb 2021 | ₹1.00 Cr | Open |
Others Creation Date: 28 Aug 2020 | ₹4.00 M | Satisfied |
Bank Of Baroda Creation Date: 19 Jul 2011 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Stereokem?
Unlock and access historical data on people associated with Stereokem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stereokem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stereokem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
